Genmab A/S
GNMSF
$274.75
$9.913.74%
OTC PK
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -94.64% | 65.52% | 1.56% | 1.56% | 469.38% |
| Total Depreciation and Amortization | -34.15% | 14.29% | 23.08% | 23.08% | 26.97% |
| Total Amortization of Deferred Charges | 75.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 97.70% | -281.37% | 102.13% | 102.13% | -244.53% |
| Change in Net Operating Assets | 20,558.12% | -5.00% | 22.95% | 22.95% | -88.98% |
| Cash from Operations | -28.96% | -71.69% | 31.05% | 31.05% | 75.54% |
| Capital Expenditure | 7.73% | -150.00% | -200.00% | -200.00% | -45.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -8,594.26% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4,403.88% | -93.04% | 84.95% | 84.95% | 167.92% |
| Cash from Investing | -9,139.39% | 102.05% | 79.52% | 79.52% | 5.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -198.20% | -33.33% | 33.33% | 33.33% | 97.32% |
| Issuance of Common Stock | 167.28% | 200.00% | -88.89% | -88.89% | -70.90% |
| Repurchase of Common Stock | 87.23% | 7.06% | 86.81% | 86.81% | -291.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 24,375.65% | 7.73% | 84.71% | 84.71% | -578.21% |
| Foreign Exchange rate Adjustments | -122.72% | 64.29% | 900.00% | 900.00% | 119.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -112.80% | 78.54% | 410.39% | 410.39% | 319.18% |